toxylact

The first professional lActological database in the word

Beclometasone (ATC A07EA07): Toxicological-Lactological Monograph

ATC class and general pharmacology

A07EA07 designates beclometasone, classified within the alimentary tract and metabolism group as an intestinal anti-inflammatory corticosteroid acting locally. WHO ATC/DDD Indexatcddd.fhi

For intestinal use, beclometasone is commonly administered as beclometasone dipropionate in gastro-resistant, prolonged-release oral formulations. A 5 mg formulation is indicated as add-on therapy for active mild-to-moderate ulcerative colitis in patients with insufficient response to 5-aminosalicylate therapy. Clipper Summary of Product Characteristicsmedicines.org

Beclometasone dipropionate is a glucocorticoid prodrug, with beclometasone-17-monopropionate as its pharmacologically active metabolite. Its therapeutic activity is mediated by glucocorticoid-receptor-dependent suppression of intestinal inflammatory pathways, including reduced inflammatory-cell recruitment and cytokine activity. Clipper Summary of Product Characteristicsmedicines.org

The prolonged-release intestinal formulation aims to maximize local colonic exposure while reducing systemic corticosteroid activity. After oral administration of 5 mg, systemic availability of the active metabolite is approximately 20% relative to intravenous exposure. Clipper Summary of Product Characteristicsmedicines.org

Toxicological profile

Beclometasone can cause systemic glucocorticoid toxicity despite its predominantly local intestinal action. The principal toxicological concern is suppression of the hypothalamic-pituitary-adrenal axis, which can reduce the physiological stress response during severe infection, trauma, or surgery. Clipper Summary of Product Characteristicsmedicines.org

In clinical studies of oral beclometasone dipropionate 5 mg, reduced plasma cortisol concentrations after four weeks occurred in up to 25% of patients, although clinical manifestations of adrenal insufficiency were not reported during the limited treatment period. HPA-axis recovery is expected after withdrawal, but prolonged treatment requires clinical vigilance. Clipper Summary of Product Characteristicsmedicines.org

Uncommon adverse effects reported with the 5 mg intestinal formulation include anxiety, headache, somnolence, nausea, constipation, abdominal pain, muscle cramps, menorrhagia, influenza-like illness, and pyrexia. Clipper Summary of Product Characteristicsmedicines.org

Higher doses or prolonged systemic exposure may produce class-related corticosteroid effects, including adrenal suppression, cushingoid features, increased infection susceptibility, lymphocyte changes, obesity, osteoporosis, cataract, glaucoma, benign intracranial hypertension, psychiatric reactions, and visual disturbance. Clipper Summary of Product Characteristicsmedicines.org

Potentially serious psychiatric effects, including depression, mood instability, anxiety, psychosis, and suicidal ideation, may occur with systemic corticosteroid exposure and can emerge during treatment or dose reduction. Clipper Summary of Product Characteristicsmedicines.org

Lactation pharmacology and infant exposure

Direct studies measuring beclometasone or beclometasone-17-monopropionate concentrations in human milk after oral intestinal treatment have not been published. Infant serum concentrations and formal relative infant dose estimates are likewise unavailable. LactMed: Beclomethasonencbi.nlm.nih

The expected infant exposure is nevertheless low because oral beclometasone has limited maternal systemic availability and low oral bioavailability. These properties reduce both transfer into milk and systemic absorption of any drug ingested by the infant. Specialist Pharmacy Servicesps.nhs

LactMed notes that systemic absorption of inhaled corticosteroids is low and that expert opinion considers inhaled, nasal, and oral corticosteroids acceptable during breastfeeding. However, this conclusion for beclometasone is based mainly on pharmacological characteristics and class experience rather than direct milk-transfer data for oral intestinal formulations. LactMed: Beclomethasonencbi.nlm.nih

The manufacturer’s product information takes a more conservative position, stating that excretion of beclometasone dipropionate into human milk is unknown and that use during lactation should be reserved for cases in which it is strictly indicated after an individual benefit-risk assessment. Clipper Summary of Product Characteristicsmedicines.org

Lactological safety assessment and clinical recommendations

Oral beclometasone is considered a preferred corticosteroid option during breastfeeding by the UK Specialist Pharmacy Service because of its low systemic absorption and low oral bioavailability. Specialist Pharmacy Servicesps.nhs

For a healthy, full-term infant, treatment with the lowest effective maternal dose for the shortest effective duration is generally compatible with continued breastfeeding. Routine interruption of breastfeeding or milk discarding is not normally required. Specialist Pharmacy Servicesps.nhs

During prolonged therapy, high-dose exposure, or circumstances that increase maternal systemic exposure, the infant should be observed for adequate feeding, normal growth, satisfactory weight gain, and possible features of adrenal suppression. Specialist Pharmacy Servicesps.nhs

A more cautious individualized assessment is appropriate for preterm, unwell, or medically complex infants, as well as when the infant has concurrent exposure to other medicines with potential adrenal effects. Specialist Pharmacy Servicesps.nhs

Maternal disease control remains important during lactation, and active ulcerative colitis should not be undertreated solely because of breastfeeding. Clinical decisions should balance the limited direct lactation evidence against the low anticipated infant exposure and the consequences of uncontrolled maternal intestinal inflammation. Specialist Pharmacy Servicesps.nhs

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.